Treatment of ERα(+) breast cancer cells and tissue with E2 led to stimulated growth and up-regulated Bcl-2 expression; however, these carcinogenic effects were diminished by either CLA or Tam and were suppressed further by the combination of CLA and Tam. The gene discussed is ESR1; the disease is breast cancer.